Spots Global Cancer Trial Database for Exercise to Boost Response to Checkpoint Blockade Immunotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Exercise to Boost Response to Checkpoint Blockade Immunotherapy
Official Title: Exercise to Boost Response to Checkpoint Blockade Immunotherapy
Study ID: NCT06008977
Interventions
Study Description
Brief Summary: The purpose of this pilot study will be to provide i) information on feasibility implementing an exercise intervention trial among patients with cutaneous cancers, including melanoma, squamous cell carcinoma (cuSCC), and Merkel cell carcinoma, scheduled to receive checkpoint blockade immunotherapy, and ii) preliminary data on the impact of a day-of-therapy exercise intervention.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
AdventHealth Translational Research Institute, Orlando, Florida, United States
Contact Details
Name: Bret Goodpaster, PhD
Affiliation: Study Principal Investigator
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
